The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients
The DOI matches its Crossref record; 44 of the 48 references it cites were found in a registry or an index.
Abstract
Background: Hypopituitary patients with untreated GH deficiency and patients on inappropriately high doses of glucocorticoid (GC) share certain clinical features. Objective: The aim of the study was to examine the influence of GC substitution on clinical characteristics in hypopituitary patients before and after GH replacement therapy. Method: A total of 2424 hypopituitary patients within the KIMS (Pfizer International Metabolic Database) were grouped according to ACTH status. Comparisons were performed between subjects on hydrocortisone (HC) (n = 1186), cortisone acetate (CA) (n = 487), and prednisolone/dexamethasone (n = 52), and ACTH-sufficient patients (AS) (n = 717) before and after 1 yr of GH treatment in terms of body mass index, waist and hip circumference, blood pressure, glucose, glycosylated hemoglobin (HbA1c), serum lipids, IGF-I, and comorbidity. Hydrocortisone equivalent (HCeq) doses were calculated, and measurements were adjusted for sex and age. Results: At baseline, the HC group had increased total cholesterol, triglycerides, waist circumference, and HbA1c, and the prednisolone/dexamethasone group had increased waist/hip ratio as compared with AS. After HCeq dose adjustment, the HC group retained higher HbA1c than the CA group. GC-treated patients showed a dose-related increase in serum IGF-I, body mass index, triglycerides, low-density lipoprotein cholesterol and total cholesterol levels. Subjects with HCeq doses less than 20 mg/d (n = 328) at baseline did not differ from AS in metabolic endpoints. The 1-yr metabolic response to GH was similar in all GC groups and dose categories. All new cases of diabetes (n = 12), stroke (n = 8), and myocardial infarction (n = 3) during GH treatment occurred in GC-treated subjects. Conclusion: HCeq doses of at least 20 mg/d in adults with hypopituitarism are associated with an unfavorable metabolic profile. CA replacement may have metabolic advantages compared with other GCs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrospective studies of patients taking higher doses of glucocorticoids in some cases, including prednisolone or dexamethasone, appear to show a tendency to adverse metabolic consequences including weight gain, dyslipidemia, and diabetes mellitus (102).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [102]
In the citing paper
“When patients cut their GC dose in half (from 20-30 mg to 10-15 mg HC daily), mean body weight decreased by 7.1 kg after 6-12 months (209).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [209]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“Serum total cholesterol (TC) (15), triglycerides (16), and high-density lipoprotein cholesterol (HDL-C) (17) were measured as previously described, and low-density lipoprotein cholesterol (LDL-C) was calculated by the Friedewald formula (18).”
MethodSerum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide.
Fossati, P., & Prencipe, L. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.10.2077 · Cited by 2,905 · cited 1×
“Serum total cholesterol (TC) (15), triglycerides (16), and high-density lipoprotein cholesterol (HDL-C) (17) were measured as previously described, and low-density lipoprotein cholesterol (LDL-C) was calculated by the Friedewald formula (18).”
MethodCholesterol determination in high-density lipoproteins separated by three different methods.
Lopes-Virella, M. F., Stone, P., Ellis, S., & Colwell, J. A. (1977) · Clinical Chemistry · doi:10.1093/clinchem/23.5.882 · Cited by 1,841 · cited 5×
“This study was carried out in Eu- First Published Online August 8, 2006 Abbreviations: AE, Adverse event; AS, ACTH-sufficient (patients); BMI, body mass index; BP, blood pressure; CA, cortisone acetate; CI, confidence interval; DHEA, dehydroepiandrostenedione; DHEAS, DHEA sulfate; DM, diabetes mellitus; DX, dexamethas…”
MethodInfluentialGlucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,066
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006 · cited 1×
“This could explain some of the metabolic features and increased cardiovascular mortality associated with severe GHD (9).”
BackgroundThe natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730 · cited 1×
“ease, with no safe lower dose threshold (38, 39).”
BackgroundDaily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481 · cited 8×
“Recently, a reduction in GC dose has been advocated because physiological cortisol production has been shown to be lower than previously thought (10).”
BackgroundInfluentialCanalis, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3441 · Cited by 463
Brabant, G., von zur Mühlen, A., Wüster, C., Ranke, M. B., Kratzsch, J., Kiess, W., Ketelslegers, J.-M., Wilhelmsen, L., Hulthén, L., Saller, B., et al. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071871 · Cited by 360 · cited 1×
“In subsequent years, a chemiluminescence immunoassay was used (Nichols Advantages system) (20).”
MethodSelf-citation
Cited by
Items 301–346 of 346
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-22102-6.00004-4
Minimising Cardiometabolic Risk Factors in Patients with Hypopituitarism
Armeni, E., & Grossman, A. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_20 · Cited by 1
Glucocorticoid treatment: clinical consequences and effects on the HPA axis
Vulto, A. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.238499726
Li, T., Li, S., Liu, H., Tan, H., Li, J., Li, J., & Yu, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3912731/v1
Cardiovascular and Metabolic Comorbidities in Pituitary Disorders
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5034-2
Betterle, C., Sabbadin, C., & Presotto, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00056-4
Outcomes of ST-Segment Elevation Myocardial Infarction in Patients With Adrenal Insufficiency
Abdallah, N., Mohamoud, A. A., Ismayl, M., Aronow, H. D., Abdallah, M., & Goldsweig, A. M. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae186
Donegan, D. M., & Glynn, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00149-7
Long-term complications of hypercortisolism
Pivonello, R., Crescenzo, E. M., Simeoli, C., Paola, N. D., Larocca, A., & Colao, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00123-0
Steroid replacement in adrenal insufficiency
Blair, J., Debono, M., & Ross, R. J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00147-3
Fettstoffwechselstörungen bei endokrinen Erkrankungen: Einfluss auf das kardiovaskuläre Risiko
König, A., Bintaro, S., & Leitolf, H. (2024) · CardioVasc · doi:10.1007/s15027-024-3692-y
“Unter exogener Glucocorticoidzufuhr konnte eine Studie eine Dosisabhängigkeit der oben angegebenen Veränderungen der Li-pidparameter beschreiben, wobei hier u. a. zwei Gruppen mit Einnahme einer Hyd-rocortison-Äquivalenzdosis von < 20 mg/ Tag und von > 20 mg/Tag verglichen wurden [21].”
Diabetes &endocrinology: something for everyone
Pearson, E. R. (2009) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520093901020
Zaffari, J. P. (2025) · STUDIES IN HEALTH SCIENCES · doi:10.54022/shsv6n1-004
Ferrière, A., & Tabarin, A. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.07.002
ABDOMINOPLASTIA: BENEFÍCIOS E MALEFÍCIOS EM PACIENTES PÓS-BARIÁTRICA
Martins, E. M., de Oliveira, M. C. D. C., Simão, A. L. A., Matos, B. X., Palhares, T. M., Machado, B. N. P., Viza, L. A., Elias, P. H. A., Boaventura, T. G. M., Vargas, A. B., et al. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_14
Zaffari, J. P. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_6
TÉCNICAS CORPORAIS DE SURFISTAS BRASILEIROS: NOTAS SOBRE A PERFORMANCE DAS MANOBRAS
de Souza, T. S., Bandeira, M. M., & Rigo, L. C. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_1
MOOCS NA EDUCAÇÃO EM SAÚDE: REVISÃO INTEGRATIVA DE LITERATURA
Tacara, S., Freire, M. H. D. S., Nakano, I. T., Foggiatto, J. A., & Hoffmann, E. C. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_12
Braga, I. A., Cunha, S. P., Costa, D. P., Chaves, D. C. C., Duarte, D. F. D. C., Carneiro, S. I. F., Dias, L. D. S., & Lima, J. B. P. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_9
IMPLEMENTAÇÃO DE TECNOLOGIAS DIGITAIS NA GESTÃO DO CUIDADO EM SAÚDE
Sarinho, A. P. M., da Silva, V. C. V., Ferreira, C. R., Brito, M. D., Sampaio, J. G. D. S., Oliveira, S. X., de Souza, R. F. R. C., Victor, J. A., Giuliani, C. D., Motta, R. F., et al. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_19
Ferreira, F. A., Pinheiro, I., Maeda, A. A. D. L., Fernandes, C. B., Menezes, R. B., Rodrigues, L. A., & Ferreira, J. J. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_8
da Silva, G. P. G., & de Oliveira, L. S. C. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_5
RISCOS OCUPACIONAIS DOS VENDEDORES AMBULANTES DA VIA FERROVIÁRIA DO RIO DE JANEIRO
de Abreu, A. B., & Basílio, E. D. A. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_15
de Carvalho, E. S., Cerreti, L. B., Gomes, C. R., Dutra, L. M. M., Verçosa, A. A., Verçosa, L. A., & Barbosa, T. H. P. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_7
SAÚDE MENTAL E TRABALHO: RELATO DE EXPERIÊNCIA EM UMA INDÚSTRIA AVÍCOLA
de Andrade, J. P., Barros, A. B. C., Guerra, A. L. P., Faria, G. R., Ribeiro, I. F., Silva, L., Machado, M. C., & Naves, E. F. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_18
Menezes, G. B., Pompeu, G. V. M., de Oliveira, C. B., de Morais, A. C. L. N., Camargo, E. E. S., & Bandeira, M. A. M. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_3
Valácio, C. C., & Machado, C. J. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_10
Santana, N. A. D. A., Pimentel, A. L. M. R., Vaz, C. M. C., Nogueira, L. Y. K., Barreto, L. P., Lopes, A. K. A. D. O., Alves, B. C., & Cavalcante, L. L. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_13
Miranda, G. A. F., Queiroz, R. A. M., Ramos, M. V., Silva, J. M. O., Daher, G. F., Tavares, E. M., Rosa, A. M. A., Sica, T. F., Neto, J. A. L., & Mourão, M. D. G. S. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_21
Motta, J. M. D. C. O., Neves, R. B. S., Cruz, L. P., & Lodi, M. D. D. F. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_22
Ricci, A. L. S., Masselai, A. L., Veiga, I. S., Teixeira, M. C. L., Ferreira, M. C., Cunha, M. R. F., Tauchmann, R., & Ruedas, V. R. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_20
Farias, A. T., & Scotta, S. G. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_17
Health, personal quests and professional dilemmas
(2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7
A EXPERIÊNCIA DO LUTO DE CUIDADORES FAMILIARES DE PESSOAS COM DEMÊNCIA
Barbosa, K. K. D. S., Agra, G., Freire, F. M. D. S., de Andrade, D. M., Suassuna, A. A., Pinto, V. G. F., Teixeira, G. D. S., & Silva, F. L. D. L. (2025) · Editora Studies Publicações eBooks · doi:10.54033/stebook.978-65-83309-29-7_4
Adrenal Insufficiency: Diagnostic Approaches, Treatments, and Outcomes Volume II
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7003-6
Yu, K., & Bancos, I. (2026) · Pituitary · doi:10.1007/s11102-026-01652-2
“Although glucocorticoid replacement is lifesaving, currently available regimens do not replicate physiological cortisol exposure, and both under-and over-replacement are associated with adverse outcomes [ 2–5].”
InfluentialPredictors of Quality of Life in Craniopharyngioma after Endoscopic Endonasal Surgery
Castle‐Kirszbaum, M., Banting, J., Evans, L. R., King, J. A., Wang, Y. Y., Kam, J., & Goldschlager, T. (2026) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/a-2872-5354
Chiloiro, S., Vicari, A., Giampietro, A., Costanza, F., Calandrelli, R., Mattogno, P. P., D’Alessandris, Q. G., Gaudino, S., Marinis, L. D., Doglietto, F., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01726-1
“Filipsson et al. demonstrated that patients undergoing GC replacement therapy had higher waist circumference ( p < 0.01), waist-hip ratio p < 0.01), glycosyl - ated hemoglobin (HbA1C) ( p < 0.0001), total cholesterol ( p < 0.05), and triglyceride ( p < 0.001) levels [ 19].”
InfluentialCardiovascular morbidity in acromegaly during a long-term follow-up—a nationwide cohort study
Partanen, A., Peltola, E., Huhtala, H., Ryödi, E., Rantala, H., Louhelainen, J., Sumrein, K., Metso, S., Markkanen, H. M., Rosengård‐Bärlund, M., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag180
NING, C., Zhang, R., Liu, W., Zhou, X., Sun, Y., Han, X., Ji, L., & Ren, Q. (2026) · Endocrine Connections · doi:10.1530/ec-26-0304
Endocrine Disorders in Older Adults
Austin, H., & Treitl, D. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2026.08.013
Codeine-Associated Secondary Adrenal Insufficiency: A Case Report
Varghese, E. A., Zachariah, N. T., & Zachariah, S. (2026) · Cureus · doi:10.7759/cureus.118882
Rodríguez, E. F. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Outcomes and optimal treatment of patients with Acromegaly.
Ayuk, J. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Metadata
- Authors
- Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G.
- Affiliations
- Department of Endocrinology (H.F., G.J.), Sahlgrenska Academy at Gothenburg’s University, SE-413 45 Gothenburg, Sweden
- St Bartholomew's Hospital (GB)
- KIGS/KIMS/ACROSTUDY Medical Outcomes (M.K.-H., A.M.), Endocrine Care, Pfizer, SE-191 90 Sollentuna, Sweden
- Pfizer (Sweden) (SE)
- University of Gothenburg (SE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-10-01
- Volume
- 91
- Issue
- 10
- Pages
- 3954-3961
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2137769079
- Cited by
- 321
- References
- 48
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 25 · 2023: 12 · 2022: 13 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 16 · 2017: 16 · 2016: 25 · 2015: 20 · 2014: 23 · 2013: 12 · 2012: 19
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Chalmers Research (Chalmers University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- hypopituitarism, glucocorticoid replacement therapy, cortisol, cortisone acetate, prednisolone, dexamethasone, growth hormone replacement therapy, metabolic profile, body mass index, waist circumference, serum lipids, HbA1c, insulin-like growth factor I, diabetes mellitus, stroke, myocardial infarction, comorbidities, glucocorticoid dose
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Aged, Female, Glucocorticoids, Humans, Hypopituitarism, Insulin-Like Growth Factor I, Lipids, Male, Middle Aged, Risk Factors, Growth Hormone, Comorbidity, Body Mass Index, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.